Maintenance Capecitabine Plus Best Supportive Care Versus Best Supportive Care for Metastatic Nasopharyngeal Carcinoma
Status:
Completed
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This multicenter, randomised, phase 3 study is to evaluate the survival benefit of
maintenance capecitabine plus best supportive care versus best supportive care for metastatic
nasopharyngeal carcinoma patients after disease controlled with TPC palliative chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University Affiliated Cancer Hospital of Shantou University Medical College Affiliated Tumor Hospital of Guangzhou Medical University Cancer Hospital of Shantou University